Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-808-0 | CAS number: 68608-89-9 This substance is identified by SDA Substance Name: C11-C13 branched alkyl benzene sulfonic acid sodium salt and SDA Reporting Number: 25-097-04.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vivo
Description of key information
The key study examined the potential of the test substance, analogue LAS acid, to cause mutations in the NMRI strain of mice. Mice (40 of males, 22-25 grams; 40 females, 20-25 grams) were exposure via oral gavage to a single dose of 1122 mg/kg bw. After 72 hours, cells were taken from the thigh, purified by centrifugation and column chromatography, Giemsa stained and evaluated for polychromatid erythrocytes (PCEs), the ratio of PCEs to normochromatid erythrocytes and the number of cells with micronuclei. No significant increase in the number of PEC with micronuclei were observed. The test substance is considered negative (not mutagenic) in the mouse micronucleus test
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP laboratory study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Strain NMRI. Animals were approximately 22-26 g (male) and 20-25 g (female) and acclimated for 1 week to the test conditions (20 =/- 3 degrees C, 30-70% relative humidity, 12 hour light/dark cycle). Food was given daily and water was ad libitum. All animals were healthy at the time of test initiation.
- Route of administration:
- oral: gavage
- Vehicle:
- NaCl
- Duration of treatment / exposure:
- 72 hours
- Frequency of treatment:
- single dose
- Remarks:
- Doses / Concentrations:
1122 mg/kg
Basis:
actual ingested - No. of animals per sex per dose:
- 40 males and 40 females per dose
- Control animals:
- yes
- Positive control(s):
- Endoxan (cyclophosphamid)
- Tissues and cell types examined:
- Cells were taken from the thigh.
- Details of tissue and slide preparation:
- Cells were mixed with cattle serum and suspended, then centrifuged. The sediment was then resuspended. The suspension was seperated in a cellulose chromatography column. This was centrifuged, and mixed with fetal calf serum and EDTA. This was air-dried for 24 hrs and stained with Giemsa.
- Evaluation criteria:
- number of polychromatid erythrocytes (PCE)
ratio of PCE to normochromatid erythrocytes (NCE)
number of cells with micronucleus - Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Interpretation of results (migrated information): negative
No significant increases in the number of polychromatic erythrocytes with micronuclei were observed. - Executive summary:
In a study with analogue LAS acid, no significant increases in the number of polychromatic erythrocytes with micronuclei were observed. The test substance is considered negative (not mutagenic) in the mouse micronucleus test.
Reference
No significant increases in the number of polychromatic erythrocytes with micronuclei were observed.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Additional information from genetic toxicity in vivo:
In cases where data on BABS Na is not available, data on analogue substances are used. The analogue substances included: 1) linear alkylbenezene sulfonate (commonly known as LAS), 2) the calcium salt of branched alkylbenzene sulfonate (commonly known as Branched CaDDBS) and 3) linear alkylbenzene sulfonic acid (commonly known as LAS acid). LAS is the sodium salt of linear alkylbenzene sulfonic acid with alkyl carbon chain lengths ranging from C10 to C13 and averaging 11.6. The primary structure is a C10 to C13 linear alkyl chain with a para-substituted benzene sulfonic acid sodium salt group attached at any of the secondary alkyl carbon positions. Branched CaDDBS is the calcium salt of branched alkylbenzene sulfonic acid with alkyl chain lengths ranging from C11 to C13. The primary difference between LAS and BABS Na salt is the alkyl chain, branched vs. linear. The primay difference between LAS and BABS Na salt is the alkyl chain, branched vs. linear. The primary difference between Branched CaDDBS and BABS Na salt is the salt, calcium vs. sodium. Because LAS Acid is neutralized in test medium or under physiological testing conditions, i.e. when tested in vivo, the primary differences between LAS Acid and BABS Na salt are the alkyl chains, branched vs. linear. Given their structural and functional similarities, LAS, Branched CaDDBS, and LAS acid are good analogues for read-accross for instances where data are available on them but not on BABS Na salt.
Three in vitro and one in vivo studies were available on analogues of BABS Na salt, including the branched calcium salt analogue (Branched CaDDBS), and a linear sodium salt (LAS) analogue. Ames studies on both Branched CaDDBS and LAS showed them to be non-mutagenic. A third study performed on LAS showed it to be non-mutagenic in mammalian cells. The key study examined the potential of the test substance, analogue LAS Acid, to cause mutations in the NMRI strain of mice. Mice (40 males, 22 -25 grams; 40 females, 20 -25 grams) were exposed via oral gavage to a single dose of 1122 mg/kg bw. After 72 hours, cells were taken from the thigh, purified by centrifugation and column chromatography, Giemsa stained and evaluated for polychromatid erythrocytes (PCEs), the ratio of PCEs to normochromatid erythrocytes and the number of cells with micronuclei. No significant increase in the number of PEC with micronuclei were observed. The test substance is considered negative (not mutagenic) in the mouse micronucleus test.
Justification for selection of genetic toxicity endpoint
Four studies on genetic toxicity were available on analogue substances. All studies showed the analogue substances were non-mutagenic. The key study was selected on the basis of it being the only in vivo study.
Justification for classification or non-classification
Based on the data available on LAS, Branched CaDDBS, and LAS acid, BABS Na salt is not classified for mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.